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Background: Reconstruction of large-size abdominal wall defect (AWDs) is a huge challenge faced in current surgical
practice. In this study, we aimed to evaluate the effectiveness and safety of biodegradable poly-p-dioxanone (PDO)
mesh for reconstructing large-size AWDs in an experimental canine model.
Methods: Eighteen experimental canines were randomly and equally divided into three groups, namely, a PDO group,
a Marlex group and a control group (n = 6 each). Following the creation of a 6 cm × 5.5 cm AWD, PDO mesh and
Marlex mesh were used to reconstruct the defect in the PDO and Marlex groups, respectively. The defect was
closed using relaxation sutures alone in the control group. Animals were killed 24 weeks after surgery, and
reconstruction outcomes were evaluated using radiography, histology and biomechanical testing.
Results: All animals except those in the control group survived the experiment. The PDO group showed no wound
dehiscence, herniation or infection, whereas the animals in the Marlex group exhibited marked foreign body reactions.
The PDO group had less intraabdominal adhesion than the Marlex group. As shown by radiography, histology
and biomechanical testing, PDO mesh exhibited complete degradation and favorable biochemical strength at
24 weeks postsurgery.
Conclusions: PDO mesh implantation is an effective, safe treatment modality for reconstructing large-size AWDs.
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Abdominal wall defects (AWDs) occur mainly after
abdominal wall trauma or tumor resection and occa-
sionally as congenital malformations. Small-size AWDs
can be closed easily using the residual abdominal wall
soft tissues; however, reconstruction of large-size AWDs
normally require the use of prostheses and remain a
huge challenge in current general surgical practice. The
challenges are the hernias with rings greater than 10
cm in diameter, which are more likely to recur [1-4].
It is essential to optimize the choice of mesh materials
for successful AWD reconstruction. A series of synthetic,* Correspondence: Qin-Xiong@163.com; lordth1982@163.com
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reproduction in any medium, provided the ornondegradable mesh prostheses, such as Marlex [5] and
polypropylene, have been examined in preclinical and
clinical studies. However, use of polypropylene for recon-
structing large-size AWDs can lead to some complications,
such as chronic pain, abdominal wall stiffness, mesh
dislocation and wound fistulas [6,7]. This material is
also reported to be associated with a high risk of
intraabdominal adhesion, which may lead to ileal and
enteric fistulas [8-10]. Developments in materials sci-
ence and technology have led to the evolution of mesh
prostheses into biodegradable material, such as human
acellular dermal matrix [11] and small-intestine submucosa
[12]. These two materials are derived from human or
animal tissue and are beneficial for tissue regeneration
[11,12], but they are primarily disadvantageous with regard
to fast reabsorption and poor long-term mechanical
strength. Furthermore, the cost of these biological meshes
is 10 to 70 times greater than the cost of synthetic meshes,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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regard to efficacy [13-16]. Composite meshes with pro-
tease-treated bovine skin collagen (atelocollagen) are
currently available, but increased infection susceptibility
and long-term coating failure have been reported [17,18].
Rapid degradation of biodegradable materials compromises
the mechanical stability and consequently limits the use
of these materials in large-size AWD reconstruction.
Poly-p-dioxanone (PDO) is a colorless, crystalline,
resorbable polymer that is degraded by hydrolysis and
completely metabolized in the body. It is available in
different thicknesses (0.15 mm perforated, 0.25 mm
unperforated and 0.55 mm unperforated), is flexible
but can preserve its shape, and can be fixed to cartilage
with sutures. Thinner plates are resorbed within 25
weeks, and thicker plates are resorbed within 8 months
[19,20]. The PDO mesh has been used for many years in
chest wall reconstruction and orbital floor reconstruction.
Researchers have demonstrated that it offers many advan-
tages, such as excellent flexibility and elasticity, as well
as suitable biocompatibility, which induces a minimal
inflammatory response [21-24].
In our previous study, we attempted to use PDO mesh
for chest wall defect reconstruction [25]. Our results
showed that PDO mesh was superior to conventional
bioabsorbable polymers mainly in terms of flexibility
and elasticity. Moreover, this material also exhibited an
appropriate reabsorption rate matching that of soft-tissue
regeneration. A knowledge gap exists regarding the use of
PDO mesh in large-size AWD reconstruction; therefore,
we conducted an experimental canine study to evaluate
the effectiveness and safety of PDO mesh alone in recon-
structing large-size AWDs.
Methods
Preparation of poly-p-dioxanone mesh
Biodegradable PDO threads (Samyang, Seoul, South Korea)
at a diameter of 0.8 mm were weaved into a mesh 7 cm
in length and 6.5 cm in width at Donghua University,
Shanghai, China. A scanning electron microscope was
used for mesh ultrastructural analysis (Figure 1).
Laboratory animals
The study protocol was approved by the Animal Care and
Use Committee of the Second Military Medical University,
Shanghai, and carried out in accordance with the latest
version of the US National Institutes of Health’s Guide for
the Care and Use of Laboratory Animals. Eighteen adult
mongrel dogs of either sex, ages 1 to 2 years and weighing
15 to 18 kg were bred and housed at the Center for
Laboratory Animals at the Second Military Medical
University. Animals were randomly and equally divided
into three groups according to the type of repair to be
performed: a PDO group, a Marlex group (crystallinepolypropylene and high-density polyethylene; Jia Te
Plastics Co, Dongguan, China) and a control group (n = 6
for each group). The first two groups underwent large-size
AWD reconstruction using PDO mesh or Marlex mesh,
respectively and the control group underwent defect
closure surgery without the use of any mesh prosthesis.Surgical procedure
An intravenous injection of pentobarbital sodium (30
mg/kg; Shanghai Suolaibao Biotechnology, Shanghai,
China) was given to induce general anesthesia, and an
intravenous infusion of ketamine hydrochloride (2 mg/
kg; Shanghai Suolaibao Biotechnology) and atracurium
besylate (0.3 mg/kg; Shanghai Suolaibao Biotechnology)
was given to maintain general anesthesia throughout
the procedure. The animals were subsequently placed
in the supine position while under general anesthesia
with endotracheal intubation. The abdominal wall skin
was shaved, sterilized with povidone-iodine (Shanghai
Suolaibao Biotechnology) and draped as routinely done.
A full-thickness midline xyphopubic AWD (6 cm× 5.5 cm)
was created, by which the fascia, underlying rectus abdom-
inis muscle and peritoneum were resected (Figure 2A). In
the PDO or Marlex mesh group, the mesh (7 cm× 6.5 cm)
was placed intraabdominally with a 0.5-cm overlap and
fixed tension-free to the abdominal wall with 2-0 polypro-
pylene sutures (Ningbo Medical Needle Co, Ltd, Ningbo,
China). Subsequently, the abdominal wall fascia was closed
at the midline with a running 2-0 polypropylene suture,
and the subcutis and skin were closed with interrupted 2-0
polypropylene sutures (Figures 2B and 2C). The defect was
closed using relaxation sutures alone in the control group
(Figure 2D). The endotracheal tube was removed when the
animal resumed spontaneous breathing. After surgery, the
animals were given an analgesic (1 ml of buprenorphine)
and an intramuscular injection of prophylactic 1,600,000-U
procaine benzylpenicillin (Shanghai Suolaibao Biotechnol-
ogy) and 80,000-U gentamicin sulfate (Shanghai Suolaibao
Biotechnology) for the first three successive days. Animals
were housed in single cages with a 12-hour day–night cycle,
fed a commercially available diet and given free access to
water. The animals were killed with an intravenous injection
of 7,000 mg of pentobarbital sodium (Shanghai Suolaibao
Biotechnology) and evaluated for clinical recurrence.Radiographic examination
To further analyze the process of mesh degradation, ab-
dominal computed tomography (CT) scans were taken
at 12 and 24 weeks following AWD reconstruction while
the animals were maintained under general anesthesia.
Image processing and three-dimensional reconstruction
were accomplished using the Advantage Workstation 4.2
(GE Healthcare, Shanghai, China).
Figure 1 Poly-p-dioxanone mesh with a pore size of 0.2 mm. (A) Gross appearance. (B) Scanning electron microscopy image (original
magnification, ×25).
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The animals were killed at 24 weeks following AWD
reconstruction. Gross wound adhesion was evaluated
using a validated semiquantitative visual analogue scale
ranging from a minimum of 0 to a maximum of 3 points
[26,27], with 0 signifying no significant adhesion; 1 indicat-
ing a thin, narrow, easily detachable adhesion; 2 meaning
a thick adhesion limited to a single area; and 3 meaning a
thick, broad adhesion involving the anterior or posterior
abdominal wall and the viscera.
Biomechanical test
Freshly harvested regenerated soft-tissue samples were
loaded onto a tensile testing machine (School of MaterialsFigure 2 Surgical procedure performed for large-size abdominal wall
(A) was created by removing bilateral rectus abdominis muscles. The AWD
(C). (D) The defect was closed using relaxation sutures in the control groupScience and Engineering Lab, Jiao Tong University,
Shanghai, China) for tensile strength measurement
with the speed calibrated at 100 mm/min at 20°C. The
load rate was set at 0.5 N/mm, and the primary load
was 1.5 N. A stress–strain curve was plotted and fitted
to produce the tensile strength and elastic modulus.
Histological examination
Regenerated soft-tissue samples were fixed in 10% formal-
dehyde (Mengzhuang Bio-Technology Co, Ltd, Beijing,
China) for 72 hours and decalcified in 15% formic acid
(Mengzhuang Bio-Technology Co, Ltd) for 2 to 6 weeks.
Tissue samples were embedded in paraffin and cut into
5-μm-thick sections with a microtome for hematoxylindefect reconstruction. A 6 cm × 5.5 cm abdominal wall defect (AWD)
was reconstructed using poly-p-dioxanone mesh (B) or Marlex mesh
.
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abdominal wall soft tissue was examined using the same
protocol used for the controls.
Statistical analysis
The SPSS version 16.0 software (IBM SPSS, Chicago, IL,
USA) was used for statistical analysis. All data are expressed
as mean ± SD. The means were compared using one-way
analysis of variance, and the two independent samples
were analyzed by Student’s t-test. P < 0.05 was considered
statistically significant.
Results
In the control group, all animals died immediately after
surgery as a result of herniation. The animals in the other
two groups survived the surgeries. The surviving animals
exhibited good general well-being and normal activities at
4, 12 and 24 weeks postsurgery. All the surviving animals
exhibited no wound dehiscence, herniation or infection
(Figure 3A), except for one dog in the Marlex group
that had a marked wound foreign body reaction and
dehiscence (Figure 3B).
On abdominal CT scans, the radiopacity of the PDO
mesh decreased but could still be observed at 12 weeks
(Figure 4A). In contrast, Marlex mesh remained radio-
paque throughout the 12 weeks after surgery (Figure 4B).
This radiopacity had mostly disappeared at 24 weeks,
indicating that the PDO mesh had nearly completely
degraded (Figure 4C). Furthermore, we observed obvious
shrinkage in the Marlex mesh group, but not in the PDO
mesh group (Figure 4D).
The proportion of adhesion was recorded for each
group. Statistical analysis of the adhesion scores was
then performed. The mean adhesion score of the PDO
mesh group was 1.1 ± 0.2, and the mean Marlex mesh
group score was 2.6 ± 0.2. Overall, PDO mesh had a
significantly lower gross wound adhesion score than
Marlex mesh (P < 0.05) (Figure 5A). All PDO meshes
became completely degraded at 24 weeks postsurgeryFigure 3 Macroscopic appearance of reconstructed abdominal wall d
exhibited good wound-healing (white arrow). (B) One animal in the Marlex g
(black arrow).with easily detachable adhesions to the peritoneum and
the omentum (Figure 5B). Marlex mesh showed no
marked degradation, but had extensive dense adhesion
to the omentum and the visceral organs, including the
omentum and the colon (Figure 5C).
To compare the normal abdominal wall and evaluate
the mechanical properties of the reconstructed abdominal
wall, the tensile strength of the implanted biomaterials
was measured at 24 weeks after surgery. The Marlex
group had significantly greater tensile strength than the
PDO group and the control group (PDO vs. Marlex vs.
control, 22.8 ± 0.4 N vs. 18.2 ± 0.3 N vs. 18.3 ± 0.3 N;
P = 0.000), whereas the PDO group exhibited tensile
strength similar to that of the control group (P = 0.664)
(Figures 6A and 6B).
PDO mesh exhibited almost complete degradation on
histological examination at 24 weeks postsurgery, and a
small amount of mesh residuals were enveloped by the
regenerated soft tissues and surrounded by extensive
fibroconnective tissues (Figure 7A). Marlex mesh showed
no microscopic degradation either (Figure 7B).
Discussion
An optimal mesh prosthesis for reconstructing AWDs
should be easily fashioned but resistant to moisture,
disinfection or mechanical tension; should not be immuno-
genic or carcinogenic; and should not cause chemical,
inflammatory, foreign body, allergic or hypersensitivity
reactions [26]. None of the currently available prosthesis
materials meet all the aforementioned requirements,
although nondegradable materials remain the mainstay
choice for large-size AWD reconstruction. However, use
of these nonbiological, nondegradable prostheses, such as
alloy fabrics and high-molecular-mass polymers, carries a
high risk of long-term complications.
Biological materials derived from autologous tissues
(fascia, muscle flap and autogenous dermis) [28], allo-
geneic tissue (amniotic membrane) [29] and xenogeneic
tissues (porcine heart valve and bovine peritoneum)efects at 12 weeks. (A) The animals in the poly-p-dioxanone group
roup had a remarkable foreign body reaction and wound dehiscence
Figure 4 Three-dimensional reconstructions of abdominal computed tomography scans. At 12 weeks, The poly-p-dioxanone (PDO) mesh
(A) and the Marlex mesh (B). At 24 weeks, On abdominal CT scans, the poly-p-dioxanone (PDO) mesh (black arrow in (C)) and the Marlex mesh
(white arrow in (D)).
Figure 5 Macroscopic evaluation of wound adhesion of reconstructed abdominal wall at 24 weeks. (A) Overall, poly-p-dioxanone (PDO)
mesh had a significantly lower gross wound adhesion score than Marlex mesh (*P < 0.05). (B) All PDO meshes became completely degraded at
24 weeks postsurgery with easily detachable adhesions to the peritoneum and the omentum. (C) Marlex mesh showed extensive dense adhesions
to the omentum and the visceral organs, including the omentum and the colon. The black and white arrows indicate the omentum and the
colon, respectively.
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Figure 6 Mechanical properties of implanted biomaterials at 24 weeks after surgery. (A) Ultimate tensile strength of each group. (B) The
statistical analysis of the ultimate tensile strength. Data are mean ± SD (n = 6). P < 0.05. PDO, Poly-p-dioxanone.
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site with a relatively lower long-term risk than nonbio-
logical materials. However, AWD reconstruction using
allograft is associated with a high risk of herniation
recurrence, mainly due to reduction in biological mesh
tensile strength and increase in elastin content in human
dermis [29]. Moreover, biomechanical properties of bio-
logical meshes are highly variable between donors [31].
Artificial synthetic mesh was first introduced by Usher
in 1958 [5], and it is widely used in general surgical
practice because of its favorable biocompatibility and
mechanical stability. As a nondegradable material, pros-
thetic mesh, such as Marlex mesh, is associated with a
series of postoperative adverse effects, including persistent
pain, hematoma, wound erosion, infection and herniation,
and even enterocutaneous fistula [1,32,33]. McKennaFigure 7 Histological images of the poly-p-dioxanone and Marlex me
sides of the reconstructed abdominal wall, respectively. (A(1)) Detailed, hig
×100). The white arrow points to the residual poly-p-dioxanone (PDO) mes
in the Marlex mesh. Images in (A) and (B) were stained with hematoxylin aet al. [34] reported an approximately 25% infection rate
associated with Marlex mesh implantation. Serious cases
normally require a second-look surgery to remove the
infectious prosthesis [34]. A large number of newly emer-
ging tissue engineering materials have been developed
for reconstructing human body wall defects in preclinical
and clinical studies based on breakthroughs in materials
science and technology [35-38]. PDO is a synthetic ab-
sorbable polymer that has been used for surgical suture
weaving. In our previous experimental canine model
study, we demonstrated that chest wall defects can be
structurally and functionally reconstructed by using a
composite implant containing PDO mesh [37]. In the
present study, we also successfully reconstructed large-
size AWDs by using PDO mesh alone. To the best of
our knowledge, this study is the first to report the useshes. (A) The white and black arrows indicate the inner and outer
h-magnification image of the boxed area in (A) (original magnification,
h. (B) The black arrow indicates the absence of soft-tissue regeneration
nd eosin (original magnification, ×10).
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experimental large-size AWDs.
In our study, PDO mesh showed good biocompatibility.
No animals in the PDO group had wound dehiscence,
herniation or infection, whereas one animal exhibited
remarkable foreign body reaction and consequent wound
nonhealing in the Marlex group. Furthermore, histological
evidence showed that PDO mesh expedited soft-tissue
regeneration by inducing collagen deposition and neoan-
giogenesis with a reasonable degradation rate over the
course of 24 weeks. In contrast, Marlex mesh showed no
signs of absorption or degradation within this period.
Researchers in similar previous studies [13] have found
that microscopically intact polypropylene mesh filaments
were surrounded by variably organized fibrous tissue, and,
as expected, a pronounced foreign body reaction and
intraabdominal adhesion formation.
Tissue adhesion usually occurs following fibrin exudation
in the wound. Our results show that PDO mesh implant-
ation caused only mild wound adhesion compared to
Marlex mesh. As a degradable material, PDO mesh is
expected to elicit minimal foreign body reaction and
inflammatory response. Shrinkage in mesh implants is
a major adverse effect, regardless of the use of degradable
or nondegradable material. This reduction results mainly
from chronic scarring and scar retraction and consequent
distortion or dislocation of the implanted mesh. The
presence of an irregularly shaped mesh surface will
induce foreign body and inflammatory reactions, which
are destructive of the newly regenerated tissue and
makes tissue prone to infection and the formation of
fistula. Our follow-up CT scans showed that remarkable
mesh shrinkage occurred in the Marlex group, but not in
the PDO group. Previous histological studies have also
confirmed that PDO mesh implantation was associated
with less serious inflammation and fibrosis, formation of
smaller granulomas and less cell turnover and remodeling
[39]. More importantly, once the initial infection has
developed, only antibiotic gauze needs to be applied to
the wound during dressing change. For synthetic, non-
degradable mesh prostheses, however, the mesh has to
be taken off. When bacteria enter the surgical incision,
the development of a mesh infection is dependent on
the bacteria adherent to the prosthetic material. Only a
clean wound can heal rapidly and without infection.
A major technical concern regarding biodegradable
mesh prostheses is long-term biomechanical strength.
No wound herniation occurred in the PDO group over
the course of 24 weeks in our present study. Postoperative
4-week follow-up CT scans showed that PDO mesh,
just as nondegradable Marlex mesh, maintained a well-
preserved shape and provided adequate mechanical
support for AWD reconstruction at an early phase.
Furthermore, 12- and 24-week postoperative CT scanssuggested that PDO mesh-regenerated tissue had sufficient
tensile and burst strength to withstand abdominal wall
tension, although the mesh had become degraded. Bio-
mechanical testing results also confirmed that PDO mesh–
regenerated tissue had favorable mechanical strength
similar to the native abdominal wall in the midterm sense,
although it was even higher in Marlex mesh.
This study has some limitations. First, for the protec-
tion of the animals, this study had a relatively small
sample size, with only six animals in each group. Second,
the follow-up period was only 24 weeks, and therefore it
remains unknown whether PDO mesh implantation was
effective and safe for large-size AWD reconstruction. In
addition, the PDO mesh was not found to be biodegraded
completely at 24 weeks postsurgery, hence it is still likely
to have retained sufficient tensile strength to prevent
failure at the surgical site and subsequent herniation.
Therefore, long-term observation is necessary in future
research. Third, PDO mesh could still induce some
intraabdominal adhesions. The most probable cause is
the fact that our PDO mesh was not coated with any
natural macromolecular biomaterial. It is known that
additional coating with artificial or biological polymers,
such as collagen, can effectively prevent the formation
of postoperative wound adhesions [40-42].
Conclusions
PDO mesh is a good alternative to Marlex mesh for large-
size AWD reconstruction. PDO mesh has a reasonable
degradation rate, good biocompatibility and sufficient
biomechanical strength similar to the native abdominal
wall in rectus abdominis. The effectiveness and safety
of using PDO mesh in reconstructing large-size AWD
needs to be validated in further long-term preclinical
and clinical studies.
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